Traws Pharma Announces Receipt Of FDA Guidance On Tivoxavir Marboxil, Plans For Pursuing Stockpiling For Pandemic Preparedness
May 27 (Reuters) - Traws Pharma Inc TRAW.O:
TRAWS PHARMA ANNOUNCES RECEIPT OF FDA GUIDANCE ON TIVOXAVIR MARBOXIL AND REPORTS PLANS FOR PURSUING STOCKPILING FOR PANDEMIC PREPAREDNESS
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
Anthropic Revenue Surpasses OpenAI for First Time, IPO as Early as October

Meta Is About to Launch a Consumer-Facing AI Model, and OpenAI Is About to Have Its IPO, Making Now a Good Time to Buy Meta Stock

IonQ vs. Rigetti Computing: Which Quantum Computing Stock Has the Edge Now?

Is Bitcoin Reaching a Local Top? Institutional Demand vs. Retail Sentiment at $70,000

Memory Chips Drive Samsung Earnings Surge, But Stock Price Opens High and Closes Lower: Why?

Tradingkey








